Spacelabs Healthcare launches Ultraview DM3 vital signs monitor

NewsGuard 100/100 Score

Combining the simplistic performance of a spot-check monitor with the sophistication of continuous monitoring, Spacelabs Healthcare's Ultraview DM3 provides caregivers with a dual-mode solution for accurately and efficiently measuring vital signs (SpO2, pulse rate, non-invasive blood pressure, respiration and temperature) on adult and pediatric patients.

“In keeping with Spacelabs' tradition of connecting innovation with care, we are pleased to introduce the Ultraview DM3, a versatile and cost-effective clinical solution, as well as an exciting addition to our expanding line of monitoring and diagnostic products”

The latest in the Ultraview series, the new DM3 can be used in any patient care environment where basic vital signs monitoring is needed. In Spot-Check mode, the DM3 supports batch collection of basic vitals for multiple patients. Supplemental patient information, such as Pain Level, Patient Position (during NIBP), Site Check, and Caregiver ID, can also be specified by the user for inclusion in the patient's record. After collection of patient vitals has been completed, the DM3 can be connected to the network to transmit the spot-check records for one or multiple patients to the hospital's EMR system.

In Monitoring mode, the DM3 provides continuous monitoring and alarm support for patients who require more vigilance. In those instances, such as following a procedure, short-term but constant monitoring may be necessary based on variable patient acuity.

"In keeping with Spacelabs' tradition of connecting innovation with care, we are pleased to introduce the Ultraview DM3, a versatile and cost-effective clinical solution, as well as an exciting addition to our expanding line of monitoring and diagnostic products," said Group President Nicholas Ong.

The Ultraview DM3 has just recently received FDA 510(k) clearance for market and sale within the United States. Plans are underway to expand marketing and sales efforts into Canada, Europe, Middle East and Africa.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Racial disparities found in delayed COVID-19 testing among healthcare workers